Jon Karch

683 total citations
5 papers, 511 citations indexed

About

Jon Karch is a scholar working on Genetics, Neurology and Pathology and Forensic Medicine. According to data from OpenAlex, Jon Karch has authored 5 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Neurology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Jon Karch's work include Glioma Diagnosis and Treatment (5 papers), CNS Lymphoma Diagnosis and Treatment (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). Jon Karch is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), CNS Lymphoma Diagnosis and Treatment (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). Jon Karch collaborates with scholars based in United States. Jon Karch's co-authors include James L. Rubenstein, Jane Fridlyand, Michael D. Prados, Marc Shuman, Michael McDermott, Chris Haqq, Arthur Shen, Joan M. O’Brien, Samar Issa and Endi Wang and has published in prestigious journals such as Journal of Clinical Oncology and Blood.

In The Last Decade

Jon Karch

5 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jon Karch United States	4	355	337	269	112	84	5	511
Anne‐Laure Taksin France	7	221 0.6×	212 0.6×	216 0.8×	95 0.8×	24 0.3×	9	611
Terrier-Lacombe Mj France	10	226 0.6×	198 0.6×	232 0.9×	161 1.4×	136 1.6×	19	543
Deb A. Bhowmick United States	11	81 0.2×	134 0.4×	71 0.3×	83 0.7×	123 1.5×	24	564
Atsufumi Kawamura Japan	9	133 0.4×	103 0.3×	113 0.4×	48 0.4×	53 0.6×	39	346
Maxime Fontanilles France	11	73 0.2×	81 0.2×	226 0.8×	95 0.8×	90 1.1×	31	480
Jan Kuhnhenn Germany	6	243 0.7×	207 0.6×	220 0.8×	44 0.4×	66 0.8×	7	590
Nathan De Beule Belgium	11	216 0.6×	165 0.5×	302 1.1×	170 1.5×	120 1.4×	22	747
Samer E. Kaba United States	8	155 0.4×	114 0.3×	84 0.3×	57 0.5×	61 0.7×	11	414
Denise Damek United States	9	176 0.5×	105 0.3×	328 1.2×	34 0.3×	143 1.7×	19	411
Gerard Donnelly United States	10	82 0.2×	260 0.8×	103 0.4×	172 1.5×	33 0.4×	12	352

Countries citing papers authored by Jon Karch

Since Specialization

Citations

This map shows the geographic impact of Jon Karch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Karch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Karch more than expected).

Fields of papers citing papers by Jon Karch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Karch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Karch. The network helps show where Jon Karch may publish in the future.

Co-authorship network of co-authors of Jon Karch

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Karch. A scholar is included among the top collaborators of Jon Karch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Karch. Jon Karch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Rubenstein, James L., Jane Fridlyand, Lauren E. Abrey, et al.. (2007). Phase I Study of Intraventricular Administration of Rituximab in Patients With Recurrent CNS and Intraocular Lymphoma. Journal of Clinical Oncology. 25(11). 1350–1356. 243 indexed citations

2.

Issa, Samar, Arthur Shen, Jon Karch, et al.. (2007). Treatment of Primary CNS Lymphoma with Induction High-Dose Methotrexate, Temozolomide, Rituximab Followed by Consolidation Cytarabine/Etoposide: A Pilot Study with Biomarker Analysis.. Blood. 110(11). 1364–1364. 2 indexed citations

3.

Roy, Sushmita, S Josephson, Jane Fridlyand, et al.. (2007). Protein Biomarker Identification in the CSF of Patients With CNS Lymphoma. Journal of Clinical Oncology. 26(1). 96–105. 113 indexed citations

4.

Issa, Samar, Justin H. Hwang, Jon Karch, et al.. (2006). Treatment of primary CNS lymphoma with induction high-dose methotrexate, temozolomide, rituximab followed by consolidation cytarabine/etoposide: A pilot study with biomarker analysis. Journal of Clinical Oncology. 24(18_suppl). 7595–7595. 3 indexed citations

5.

Rubenstein, James L., Jane Fridlyand, Arthur Shen, et al.. (2006). Gene expression and angiotropism in primary CNS lymphoma. Blood. 107(9). 3716–3723. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact